Timothy John Ritchie

Person

London, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted quinazolinones as vanilloid antagonists
- Patent number 9,102,653
- Issue date Aug 11, 2015
- Novartis AG
- Timothy John Ritchie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonists
- Patent number 9,012,451
- Issue date Apr 21, 2015
- Novartis AG
- Dominik Feuerbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinone derivatives useful as vanilloid antagonists
- Patent number 8,809,528
- Issue date Aug 19, 2014
- Novartis AG
- Timothy John Ritchie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 8,765,743
- Issue date Jul 1, 2014
- GlaxoSmithKline Intellectual Property Development Limited
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzpyrazol derivatives as inhibitors of PI3 kinases
- Patent number 8,658,635
- Issue date Feb 25, 2014
- GlaxoSmithKline Intellectual Property Development Limited
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 8,536,169
- Issue date Sep 17, 2013
- Glaxo Group Limited
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazole derivatives used as CCR4 receptor antagonists
- Patent number 8,357,716
- Issue date Jan 22, 2013
- Glaxo Group Limited
- Heather Hobbs
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists
- Patent number 8,236,803
- Issue date Aug 7, 2012
- Novartis AG
- Dominik Feuerbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinone derivatives useful as vanilloid antagonists
- Patent number 8,211,902
- Issue date Jul 3, 2012
- Novartis AG
- Timothy John Ritchie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
- Patent number 8,163,743
- Issue date Apr 24, 2012
- GlaxoGroupLimited
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinone derivatives useful as vanilloid antagonists
- Patent number 7,960,399
- Issue date Jun 14, 2011
- Novartis AG
- Timothy J Ritchie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chromone derivatives useful as antagonists of VR1 receptors
- Patent number 7,732,435
- Issue date Jun 8, 2010
- Novartis AG
- Andrew James Culshaw
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists
- Patent number 7,579,362
- Issue date Aug 25, 2009
- Novartis AG
- Dominik Feuerbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide derivatives
- Patent number 7,109,203
- Issue date Sep 19, 2006
- Novartis AG
- Terance W Hart
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bradykinin receptor antagonists
- Patent number 6,958,331
- Issue date Oct 25, 2005
- Novartis AG
- Christopher Thomas Brain
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY
- Publication number 20240166643
- Publication date May 23, 2024
- Imperial College Innovations Limited
- Edward William TATE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINONE DERIVATIVES USEFUL AS VANILLOID ANTAGONISTS
- Publication number 20140315932
- Publication date Oct 23, 2014
- Novartis AG
- Timothy John RITCHIE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Use
- Publication number 20130165433
- Publication date Jun 27, 2013
- GlaxoSmithKline Intellectual Property Development Limited
- Ian Robert Baldwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZPYRAZOLE DERIVATIVES AS INHIBITORS OF PI3 KINASES
- Publication number 20120245171
- Publication date Sep 27, 2012
- Glaxo Group Limited
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20120238559
- Publication date Sep 20, 2012
- Glaxo Group Limited
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDAZOLE DERIVATIVES AS PI 3-KINASE
- Publication number 20120238571
- Publication date Sep 20, 2012
- Glaxo Group Limited
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS
- Publication number 20120220599
- Publication date Aug 30, 2012
- Novartis AG
- Dominik FEUERBACH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINONE DERIVATIVES USEFUL AS VANILLOID ANTAGONISTS
- Publication number 20120184571
- Publication date Jul 19, 2012
- Novartis AG
- Timothy John Ritchie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrazole Derivatives Used as CCR4 Receptor Antagonists
- Publication number 20120015932
- Publication date Jan 19, 2012
- Heather Hobbs
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINONE DERIVATIVES USEFUL AS VANILLOID ANTAGONISTS
- Publication number 20110195983
- Publication date Aug 11, 2011
- Novartis AG
- Timothy John Ritchie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Compounds
- Publication number 20110183973
- Publication date Jul 28, 2011
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZPYRAZOL DERIVATIVES AS INHIBITORS OF PI3 KINASES
- Publication number 20110178063
- Publication date Jul 21, 2011
- Glaxo Group Limited
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Compounds
- Publication number 20110118246
- Publication date May 19, 2011
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-CARBOXAMIDE INDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF P13-KINASES
- Publication number 20110112070
- Publication date May 12, 2011
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Trisubstituted Quinazolinone Derivatives as Vanilloid Antagonists
- Publication number 20090082365
- Publication date Mar 26, 2009
- Novartis AG
- Gurdip Bhalay
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS
- Publication number 20090054446
- Publication date Feb 26, 2009
- Novartis AG
- Dominik FEUERBACH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinazolinone Derivatives as Vanilloid Antagonists
- Publication number 20080318940
- Publication date Dec 25, 2008
- Novartis AG
- Edward Karol Dziadulewicz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chromone Derivatives Useful as Antagonists of Vr1 Receptors
- Publication number 20080312316
- Publication date Dec 18, 2008
- Andrew James Culshaw
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinazolinone Derivatives Useful as Vanilloid Antagonists
- Publication number 20080194595
- Publication date Aug 14, 2008
- Timothy John Ritchie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chromone Derivatives Useful as Vanilloid Antagonists
- Publication number 20080114056
- Publication date May 15, 2008
- Timothy John Ritchie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
- Publication number 20070249617
- Publication date Oct 25, 2007
- Dominik Feuerbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
- Publication number 20060167002
- Publication date Jul 27, 2006
- Dominik Feuerbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sulfonamide derivatives
- Publication number 20040127533
- Publication date Jul 1, 2004
- Terance William Hart
- C07 - ORGANIC CHEMISTRY

Timothy John Ritchie

Person

Patents Grantslast 30 patents

Substituted quinazolinones as vanilloid antagonists

Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonists

Quinazolinone derivatives useful as vanilloid antagonists

Compounds

Benzpyrazol derivatives as inhibitors of PI3 kinases

Compounds

Pyrazole derivatives used as CCR4 receptor antagonists

Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists

Quinazolinone derivatives useful as vanilloid antagonists

4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases

Quinazolinone derivatives useful as vanilloid antagonists

Chromone derivatives useful as antagonists of VR1 receptors

Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists

Sulfonamide derivatives

Bradykinin receptor antagonists

Patents Applicationslast 30 patents

IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY

QUINAZOLINONE DERIVATIVES USEFUL AS VANILLOID ANTAGONISTS

Novel Use

BENZPYRAZOLE DERIVATIVES AS INHIBITORS OF PI3 KINASES

NOVEL COMPOUNDS

INDAZOLE DERIVATIVES AS PI 3-KINASE

AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS

QUINAZOLINONE DERIVATIVES USEFUL AS VANILLOID ANTAGONISTS

Pyrazole Derivatives Used as CCR4 Receptor Antagonists

QUINAZOLINONE DERIVATIVES USEFUL AS VANILLOID ANTAGONISTS

Novel Compounds

BENZPYRAZOL DERIVATIVES AS INHIBITORS OF PI3 KINASES

Novel Compounds

4-CARBOXAMIDE INDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF P13-KINASES

Trisubstituted Quinazolinone Derivatives as Vanilloid Antagonists

AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS

Quinazolinone Derivatives as Vanilloid Antagonists

Chromone Derivatives Useful as Antagonists of Vr1 Receptors

Quinazolinone Derivatives Useful as Vanilloid Antagonists

Chromone Derivatives Useful as Vanilloid Antagonists

Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists

Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists

Sulfonamide derivatives